Global_fund_country_performance.png
Countries average performance (HIV, TB, and Malaria) since 2010
The Global Fund achievement in fighting HIV, TB and Malaria
Global_fund_achievements_in_fighting_malaria_tb_hiv.png
Malaria_TB_and_HIV_Prevalence.png
HIV, TB and Malaria prevalence in 2013
MENAHRA.png
The Global fund and the MENA region

Current GFO Articles

All funding requests to the Global Fund for 2017-2019 reviewed by TRP, most approved by the Board

As of 1 July 2019, the Technical Review Panel (TRP) has completed its reviews of funding requests for the 2017-2019 allocations and has issued recommendations covering all of the funds available for country allocation ($10.3 billion); all of the matching funds that were subject to TRP review ($...
21 Aug 2019
Changing the paradigm to end tuberculosis



/*-->*/

Tuberculosis (TB) is now the world’s leading infectious disease killer. In 2017, according to World Health Organisation (WHO) estimates, 10 million people fell ill with TB and 1.6 million died from the disease. While acknowledging that TB prevalence is higher among men, it is...
20 Aug 2019
Venezuela will be eligible for an allocation from the Global Fund for malaria, for 2020-2022

Venezuela will be eligible for an allocation for malaria in the next allocation period, 2020-2022. The Global Fund Board announced its approval of this decision late on 15 August, after a round of electronic voting.


In its decision, the Board cited a clause in the Global Fund’s...
20 Aug 2019
Global Fund Board approves new country and multi-country grants valued at $47.3 million

On 16 August 2019, by electronic vote, the Global Fund Board approved funding for three country grants worth $32.7 million (Colombia HIV, Honduras TB/HIV and Kazakhstan TB). Domestic commitments for the programs included in the approved country grants amounted to $1.17 billion....
20 Aug 2019
Global Fund impact on building and strengthening a health system: The example of Rwanda

The Global Fund has recognized the importance of health systems in the response to the three pandemics since its inception, but building resilient and sustainable systems for health became a strategic pillar in the Global Fund’s 2017-2022 strategy "Investing to End Epidemics". The simultaneous...
12 Aug 2019
.... .... ...

Aidspan is a non-profit organization based in Kenya whose mission is to reinforce the effectiveness of the Global Fund to Fight AIDS, Tuberculosis and Malaria by serving as an independent watchdog of the Fund and its grant implementers

Domestic financing for HIV, TB and malaria in Global Fund High Impact Asia countries
31 Jul 2019

The Global Fund to fight AIDS, Tuberculosis (TB) and malaria is a major financier of these three diseases globally. Since its inception in 2002, the Global Fund has invested more than $41 billion in more than 100 countries. The Global Fund invests the majority of its funds in countries it calls “High Impact countries”.

All Reports

Pages
A Beginner's Guide to the Global Fund Fourth Edition
04 Jan 2019

This is the fourth edition of a guide originally written by David Garmaise, then Aidspan’s Senior Analyst (david.garmaise@aidspan.org). Jeff Hoover, Kerstin Reisdorf helped with the second and third edition update, respectively. This fourth edition was updated by Samuel Muniu, Ann Ithibu, and Djesika Amendah.

All Guides

Pages
Watchdog

Pages